Latest News

Cytokinetics and Astellas Announce New Phase 2 Clinical Trial

December 23, 2014
Posted in , ,

Cytokinetics and Astellas jointly announced plans to begin a Phase 2 clinical trial in 2015 in patients with spinal muscular atrophy. The trial will test CK-2127107, a muscle activator. CK-2127107 […]

Read More ›

Help Us Make History with $750,000 for SMA Research

December 23, 2014
Posted in ,

Just over a month ago, we announced a year-end goal of $540,000 to help fund SMA research and family support. Thanks to the generosity of our community, we’re well on […]

Read More ›

Cure SMA Launches Survey on Family Support Programs

December 22, 2014
Posted in

We’ve just launched a survey to help determine the value and success of our family support and patient services programs. This survey is open to individuals affected by SMA, as […]

Read More ›

Cure SMA Announces New $50,000 Clinical Care Research Grant to Nilesh Mehta at Boston Children’s Hospital

December 19, 2014
Posted in ,

We’re excited to announce that we have awarded $50,000 clinical care grant to Dr. Nilesh Mehta, for his project focusing on nutrition in SMA. Some individuals with SMA are at […]

Read More ›

Results Published on First Large Animal Model of SMA

December 18, 2014
Posted in

Dr. Arthur Burghes, a Cure SMA Scientific Advisory Board Member from Ohio State University, has published a paper on the first-ever large animal model of SMA. There are a number […]

Read More ›

Registration Opens for the 2015 Annual SMA Conference

December 18, 2014
Posted in ,

Registration is now open for the 2015 Annual SMA Conference. The 2015 Annual SMA Conference will be held in Kansas City, MO, at the Westin Crown Center from Thursday, June […]

Read More ›
Scroll to Top